Stephen Wilson

Dr. Wilson earned a Ph.D. in Immunology from the University of Arizona’s College of Medicine and completed a post-doctoral fellowship at LJII. During his nearly 25 years at LJII, Dr. Wilson held roles of increasing responsibility, most recently serving as Executive Vice President and Chief Operating Officer. In that position, he oversaw facility operations, worked to establish research collaborations between LJII and the biomedical industry and played a central role in the institute’s evolution into a world-renowned biomedical research facility.

During his tenure, LJII grew from roughly $14 million in annual operations to more than $80 million in annual research and development. Established in 1988, LJII’s research activities have totaled more than $1 billion to date. Dr. Wilson also serves as a founding board member of Invivoscribe Technologies, Inc., a molecular diagnostics and oncology therapeutics company.